Aarey Drugs and Pharmaceuticals Ltd AAREYDRUGS.NS

₹55.90 ₹5.29 (8.65%) 1D

Last Updated: Mar 27, 12:00 AM·NSE

AAREYDRUGS.NS Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: January 11, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS.NS)

Based on 7 analysts giving stock ratings to Aarey Drugs and Pharmaceuticals Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Aarey Drugs and Pharmaceuticals Ltd

Aarey Drugs and Pharmaceuticals Ltd. Stock Analysis AAREYDRUGS.NS

India Health Care Nano Cap Report:
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 0 full-time employees. The firm is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The firm's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
Read More

Key Statistics of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹55.77₹62.42

Today's Open

₹61.19

Volume

144.24K

P/E Ratio (TTM)

43.74

52 Week Range

₹32.85₹100.00

Market Cap

1.97B

Avg. Volume

130.26K

Dividend Yield

-

Financial Metrics & Statements of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS.NS)

FAQ's for Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS.NS)

  • According to Musaffa’s Shariah screening methodology, Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.